Etripamil

艾曲帕米

Report date: 2026/03/24 20:00:35
NME

Base Information

Drug NameEtripamil
Drug Alias Name依曲帕米etripamilumetripamiloCARDAMYSTS82A18Y42P +[9] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsParoxysmal Supraventricular TachycardiaTachycardia, SupraventricularTachycardia, Paroxysmal +[5] 
Global Approved IndicationsParoxysmal Supraventricular Tachycardia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/12/12
Country/TerritoryBelgiumCanadaUnited States +[13] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesMilestone
China Registration ClassN/A

Develop Information

Active CompaniesYunding Xinyao Co LtdCorxel Pharmaceuticals IncMilestone Pharmaceuticals Inc +[5] 
Inactive CompaniesN/A
Active IndicationsParoxysmal Supraventricular TachycardiaTachycardia, SupraventricularTachycardia, Paroxysmal +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG